NEERVU Trademark

Trademark Overview


On Thursday, November 19, 2020, a trademark application was filed for NEERVU with the United States Patent and Trademark Office. The USPTO has given the NEERVU trademark a serial number of 90329978. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Visus Therapeutics Inc.. The NEERVU trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic drugs
neervu

General Information


Serial Number90329978
Word MarkNEERVU
Filing DateThursday, November 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesOphthalmic drugs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVisus Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameVisus Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 3, 2021ASSIGNED TO EXAMINER
Sunday, January 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 23, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords


neervu drugs ophthalmic